- Home
- BBIO vs QLYS Comparison
BBIO vs QLYS Comparison
Compare BBIO & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- QLYS
- Stock Information
- Founded
- BBIO 2015
- QLYS 1999
- Country
- BBIO United States
- QLYS United States
- Employees
- BBIO N/A
- QLYS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- QLYS Computer Software: Prepackaged Software
- Sector
- BBIO Health Care
- QLYS Technology
- Exchange
- BBIO Nasdaq
- QLYS Nasdaq
- Market Cap
- BBIO 4.9B
- QLYS 4.5B
- IPO Year
- BBIO 2019
- QLYS 2012
- Fundamental
- Price
- BBIO $23.24
- QLYS $150.18
- Analyst Decision
- BBIO Strong Buy
- QLYS Hold
- Analyst Count
- BBIO 13
- QLYS 18
- Target Price
- BBIO $46.92
- QLYS $154.19
- AVG Volume (30 Days)
- BBIO 1.7M
- QLYS 629.5K
- Earning Date
- BBIO 11-12-2024
- QLYS 11-05-2024
- Dividend Yield
- BBIO N/A
- QLYS N/A
- EPS Growth
- BBIO N/A
- QLYS 22.85
- EPS
- BBIO N/A
- QLYS 4.53
- Revenue
- BBIO $217,765,000.00
- QLYS $592,950,000.00
- Revenue This Year
- BBIO $3,690.39
- QLYS $11.15
- Revenue Next Year
- BBIO N/A
- QLYS $7.65
- P/E Ratio
- BBIO N/A
- QLYS $33.12
- Revenue Growth
- BBIO 2209.77
- QLYS 9.66
- 52 Week Low
- BBIO $21.62
- QLYS $119.17
- 52 Week High
- BBIO $44.32
- QLYS $206.35
- Technical
- Relative Strength Index (RSI)
- BBIO 41.84
- QLYS 63.00
- Support Level
- BBIO $21.72
- QLYS $140.31
- Resistance Level
- BBIO $27.57
- QLYS $155.93
- Average True Range (ATR)
- BBIO 1.42
- QLYS 5.83
- MACD
- BBIO -0.23
- QLYS 0.02
- Stochastic Oscillator
- BBIO 25.98
- QLYS 60.68
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.